These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Heterologous extracellular DNA facilitates the development of Pereira LMG; Andrade ARC; Portela FVM; Aguiar ALR; Silva BND; Moura SGB; Pergentino MLM; Rocha MFG; Sidrim JJDC; Castelo Branco DSCM; Cordeiro RA Biofouling; 2022 Sep; 38(8):778-785. PubMed ID: 36210505 [No Abstract] [Full Text] [Related]
6. Multiple species of Trichosporon produce biofilms highly resistant to triazoles and amphotericin B. Iturrieta-González IA; Padovan AC; Bizerra FC; Hahn RC; Colombo AL PLoS One; 2014; 9(10):e109553. PubMed ID: 25360765 [TBL] [Abstract][Full Text] [Related]
7. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin. Mariné M; Bom VL; de Castro PA; Winkelstroter LK; Ramalho LN; Brown NA; Goldman GH Virulence; 2015; 6(5):476-86. PubMed ID: 25751127 [TBL] [Abstract][Full Text] [Related]
8. In Vitro Activity of Berberine Alone and in Combination with Antifungal Drugs Against Planktonic Forms and Biofilms of Trichosporon Asahii. Cong L; Liao Y; Yang S; Yang R Mycopathologia; 2017 Oct; 182(9-10):829-837. PubMed ID: 28144822 [TBL] [Abstract][Full Text] [Related]
10. Molecular Identification, Genotyping, Phenotyping, and Antifungal Susceptibilities of Medically Important Trichosporon, Apiotrichum, and Cutaneotrichosporon Species. do Espírito Santo EPT; Monteiro RC; da Costa ARF; Marques-da-Silva SH Mycopathologia; 2020 Apr; 185(2):307-317. PubMed ID: 31776790 [TBL] [Abstract][Full Text] [Related]
11. Combinatory Effect of ALA-PDT and Itraconazole Treatment for Trichosporon asahii. Lan Y; Lu S; Zheng B; Tang Z; Li J; Zhang J Lasers Surg Med; 2021 Jul; 53(5):722-730. PubMed ID: 33164224 [TBL] [Abstract][Full Text] [Related]
12. Metabolic and phenotypic plasticity may contribute for the higher virulence of Trichosporon asahii over other Trichosporonaceae members. de Andrade IB; Figueiredo-Carvalho MHG; Chaves ALDS; Coelho RA; Almeida-Silva F; Zancopé-Oliveira RM; Frases S; Brito-Santos F; Almeida-Paes R Mycoses; 2023 May; 66(5):430-440. PubMed ID: 36564594 [TBL] [Abstract][Full Text] [Related]
13. Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres. Francisco EC; de Almeida Junior JN; de Queiroz Telles F; Aquino VR; Mendes AVA; de Andrade Barberino MGM; de Tarso O Castro P; Guimarães T; Hahn RC; Padovan ACB; Chaves GM; Colombo AL Clin Microbiol Infect; 2019 Jul; 25(7):909.e1-909.e5. PubMed ID: 30991116 [TBL] [Abstract][Full Text] [Related]
14. Biofilm formation and antifungal susceptibility of Trichosporon asahii isolates from Mexican patients. Montoya AM; Elizondo-Zertuche M; Treviño-Rangel RJ; Becerril-García M; González GM Rev Iberoam Micol; 2018; 35(1):22-26. PubMed ID: 29287630 [TBL] [Abstract][Full Text] [Related]
15. Genotyping, antifungal susceptibility testing, and biofilm formation of Trichosporon spp. isolated from urine samples in a University Hospital in Bangkok, Thailand. Wongsuk T; Boonsilp S; Pumeesat P; Homkaew A; Sangsri T; Chongtrakool P Acta Microbiol Immunol Hung; 2022 Sep; 69(3):247-257. PubMed ID: 35976734 [TBL] [Abstract][Full Text] [Related]
16. In Vitro Antifungal Activity of Sertraline and Synergistic Effects in Combination with Antifungal Drugs against Planktonic Forms and Biofilms of Clinical Trichosporon asahii Isolates. Cong L; Liao Y; Yang S; Yang R PLoS One; 2016; 11(12):e0167903. PubMed ID: 27930704 [TBL] [Abstract][Full Text] [Related]
17. Trichosporon inkin biofilms produce extracellular proteases and exhibit resistance to antifungals. de Aguiar Cordeiro R; Serpa R; Flávia Uchoa Alexandre C; de Farias Marques FJ; Vladia Silva de Melo C; da Silva Franco J; José de Jesus Evangelista A; Pires de Camargo Z; Samia Nogueira Brilhante R; Fabio Gadelha Rocha M; Luciano Bezerra Moreira J; de Jesus Pinheiro Gomes Bandeira T; Júlio Costa Sidrim J J Med Microbiol; 2015 Nov; 64(11):1277-1286. PubMed ID: 26310576 [TBL] [Abstract][Full Text] [Related]
18. Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance. Di Bonaventura G; Pompilio A; Picciani C; Iezzi M; D'Antonio D; Piccolomini R Antimicrob Agents Chemother; 2006 Oct; 50(10):3269-76. PubMed ID: 17005804 [TBL] [Abstract][Full Text] [Related]
19. Intergenic spacer (IGS-1) region sequence-based identification, genotypic analysis, and antifungal susceptibility of clinical Trichosporon species. Parashar A; Rastogi V; Prakash H; Pandey A; Rudramurthy SM Indian J Med Microbiol; 2023; 45():100390. PubMed ID: 37573054 [TBL] [Abstract][Full Text] [Related]
20. Hospital Trichosporon asahii isolates with simple architecture biofilms and high resistance to antifungals routinely used in clinical practice. Malacrida AM; Corrêa JL; Barros ILE; Veiga FF; Pereira EDCA; Negri M; Svidzinski TIE J Mycol Med; 2023 May; 33(2):101356. PubMed ID: 36563454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]